nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—LTK—mouth—autistic disorder	0.00801	0.0213	CbGeAlD
Vandetanib—STK35—hindbrain—autistic disorder	0.00564	0.015	CbGeAlD
Vandetanib—EPHA8—eye—autistic disorder	0.00488	0.013	CbGeAlD
Vandetanib—ERBB3—mouth—autistic disorder	0.00437	0.0116	CbGeAlD
Vandetanib—FYN—hindbrain—autistic disorder	0.0043	0.0114	CbGeAlD
Vandetanib—TYRO3—brainstem—autistic disorder	0.00388	0.0103	CbGeAlD
Vandetanib—EPHA5—eye—autistic disorder	0.00378	0.01	CbGeAlD
Vandetanib—TYRO3—forebrain—autistic disorder	0.00374	0.00996	CbGeAlD
Vandetanib—EPHA5—forebrain—autistic disorder	0.00374	0.00996	CbGeAlD
Vandetanib—EPHA5—telencephalon—autistic disorder	0.00344	0.00916	CbGeAlD
Vandetanib—TYRO3—telencephalon—autistic disorder	0.00344	0.00916	CbGeAlD
Vandetanib—MAP2K5—hindbrain—autistic disorder	0.00344	0.00914	CbGeAlD
Vandetanib—PTK6—digestive system—autistic disorder	0.0034	0.00904	CbGeAlD
Vandetanib—STK35—brainstem—autistic disorder	0.00323	0.0086	CbGeAlD
Vandetanib—FLT4—eye—autistic disorder	0.00292	0.00776	CbGeAlD
Vandetanib—RIPK2—eye—autistic disorder	0.0029	0.00772	CbGeAlD
Vandetanib—LTK—head—autistic disorder	0.00289	0.00769	CbGeAlD
Vandetanib—FMO1—forebrain—autistic disorder	0.00285	0.00759	CbGeAlD
Vandetanib—EPHA8—head—autistic disorder	0.00277	0.00737	CbGeAlD
Vandetanib—ERBB3—forebrain—autistic disorder	0.00275	0.00732	CbGeAlD
Vandetanib—EGFR—telencephalon—autistic disorder	0.00273	0.00726	CbGeAlD
Vandetanib—ABL1—hindbrain—autistic disorder	0.00265	0.00705	CbGeAlD
Vandetanib—VEGFA—telencephalon—autistic disorder	0.00264	0.00702	CbGeAlD
Vandetanib—EPHA5—digestive system—autistic disorder	0.00263	0.00699	CbGeAlD
Vandetanib—EPHA8—nervous system—autistic disorder	0.00263	0.00699	CbGeAlD
Vandetanib—MKNK1—eye—autistic disorder	0.00261	0.00693	CbGeAlD
Vandetanib—AXL—eye—autistic disorder	0.00256	0.00682	CbGeAlD
Vandetanib—ERBB3—telencephalon—autistic disorder	0.00253	0.00673	CbGeAlD
Vandetanib—EPHA8—central nervous system—autistic disorder	0.00253	0.00673	CbGeAlD
Vandetanib—FMO3—eye—autistic disorder	0.00249	0.00662	CbGeAlD
Vandetanib—EPHA8—cerebellum—autistic disorder	0.00247	0.00658	CbGeAlD
Vandetanib—FYN—brainstem—autistic disorder	0.00247	0.00656	CbGeAlD
Vandetanib—FYN—forebrain—autistic disorder	0.00238	0.00633	CbGeAlD
Vandetanib—MKNK1—telencephalon—autistic disorder	0.00238	0.00632	CbGeAlD
Vandetanib—AXL—telencephalon—autistic disorder	0.00234	0.00622	CbGeAlD
Vandetanib—MAP4K5—forebrain—autistic disorder	0.00233	0.00619	CbGeAlD
Vandetanib—EPHA6—head—autistic disorder	0.00231	0.00615	CbGeAlD
Vandetanib—SLK—telencephalon—autistic disorder	0.00225	0.00599	CbGeAlD
Vandetanib—EPHB6—forebrain—autistic disorder	0.00222	0.00591	CbGeAlD
Vandetanib—EPHA6—nervous system—autistic disorder	0.00219	0.00583	CbGeAlD
Vandetanib—FYN—telencephalon—autistic disorder	0.00219	0.00582	CbGeAlD
Vandetanib—YES1—eye—autistic disorder	0.00217	0.00576	CbGeAlD
Vandetanib—TYRO3—head—autistic disorder	0.00214	0.0057	CbGeAlD
Vandetanib—EPHA5—head—autistic disorder	0.00214	0.0057	CbGeAlD
Vandetanib—MAP4K5—telencephalon—autistic disorder	0.00214	0.00569	CbGeAlD
Vandetanib—TEK—telencephalon—autistic disorder	0.00214	0.00569	CbGeAlD
Vandetanib—LYN—head—autistic disorder	0.00213	0.00567	CbGeAlD
Vandetanib—EPHA6—central nervous system—autistic disorder	0.00211	0.00561	CbGeAlD
Vandetanib—BMPR1B—head—autistic disorder	0.0021	0.00559	CbGeAlD
Vandetanib—MAP3K19—head—autistic disorder	0.0021	0.00559	CbGeAlD
Vandetanib—LTK—brain—autistic disorder	0.00209	0.00557	CbGeAlD
Vandetanib—SRC—eye—autistic disorder	0.00208	0.00554	CbGeAlD
Vandetanib—SRC—forebrain—autistic disorder	0.00207	0.0055	CbGeAlD
Vandetanib—EPHB6—telencephalon—autistic disorder	0.00204	0.00544	CbGeAlD
Vandetanib—EPHA5—nervous system—autistic disorder	0.00203	0.00541	CbGeAlD
Vandetanib—TYRO3—nervous system—autistic disorder	0.00203	0.00541	CbGeAlD
Vandetanib—LYN—nervous system—autistic disorder	0.00202	0.00538	CbGeAlD
Vandetanib—RIPK2—digestive system—autistic disorder	0.00202	0.00537	CbGeAlD
Vandetanib—EPHA8—brain—autistic disorder	0.00201	0.00534	CbGeAlD
Vandetanib—FMO1—digestive system—autistic disorder	0.002	0.00533	CbGeAlD
Vandetanib—BMPR1B—nervous system—autistic disorder	0.00199	0.0053	CbGeAlD
Vandetanib—MAP3K19—nervous system—autistic disorder	0.00199	0.0053	CbGeAlD
Vandetanib—YES1—telencephalon—autistic disorder	0.00197	0.00525	CbGeAlD
Vandetanib—MAP2K5—brainstem—autistic disorder	0.00197	0.00524	CbGeAlD
Vandetanib—EPHA5—central nervous system—autistic disorder	0.00196	0.00521	CbGeAlD
Vandetanib—TYRO3—central nervous system—autistic disorder	0.00196	0.00521	CbGeAlD
Vandetanib—LYN—central nervous system—autistic disorder	0.00195	0.00518	CbGeAlD
Vandetanib—ERBB3—digestive system—autistic disorder	0.00193	0.00514	CbGeAlD
Vandetanib—BMPR1B—central nervous system—autistic disorder	0.00192	0.0051	CbGeAlD
Vandetanib—MAP3K19—central nervous system—autistic disorder	0.00192	0.0051	CbGeAlD
Vandetanib—KDR—eye—autistic disorder	0.00192	0.0051	CbGeAlD
Vandetanib—EPHA5—cerebellum—autistic disorder	0.00191	0.00509	CbGeAlD
Vandetanib—TYRO3—cerebellum—autistic disorder	0.00191	0.00509	CbGeAlD
Vandetanib—KDR—forebrain—autistic disorder	0.0019	0.00506	CbGeAlD
Vandetanib—SRC—telencephalon—autistic disorder	0.0019	0.00505	CbGeAlD
Vandetanib—BMPR1B—cerebellum—autistic disorder	0.00187	0.00498	CbGeAlD
Vandetanib—MKNK1—digestive system—autistic disorder	0.00181	0.00483	CbGeAlD
Vandetanib—FGR—digestive system—autistic disorder	0.00179	0.00477	CbGeAlD
Vandetanib—RET—digestive system—autistic disorder	0.00179	0.00477	CbGeAlD
Vandetanib—STK35—head—autistic disorder	0.00179	0.00475	CbGeAlD
Vandetanib—MAP2K5—telencephalon—autistic disorder	0.00175	0.00465	CbGeAlD
Vandetanib—STK35—nervous system—autistic disorder	0.00169	0.0045	CbGeAlD
Vandetanib—EPHA6—brain—autistic disorder	0.00167	0.00445	CbGeAlD
Vandetanib—FYN—digestive system—autistic disorder	0.00167	0.00444	CbGeAlD
Vandetanib—PDGFRB—eye—autistic disorder	0.00166	0.00441	CbGeAlD
Vandetanib—FLT4—head—autistic disorder	0.00166	0.0044	CbGeAlD
Vandetanib—PLK4—brain—autistic disorder	0.00165	0.0044	CbGeAlD
Vandetanib—RIPK2—head—autistic disorder	0.00165	0.00438	CbGeAlD
Vandetanib—FMO1—head—autistic disorder	0.00163	0.00434	CbGeAlD
Vandetanib—STK35—central nervous system—autistic disorder	0.00163	0.00434	CbGeAlD
Vandetanib—FLT3—cerebellum—autistic disorder	0.00163	0.00433	CbGeAlD
Vandetanib—IRAK4—head—autistic disorder	0.00161	0.00428	CbGeAlD
Vandetanib—STK35—cerebellum—autistic disorder	0.00159	0.00424	CbGeAlD
Vandetanib—ERBB3—head—autistic disorder	0.00158	0.00419	CbGeAlD
Vandetanib—TYRO3—brain—autistic disorder	0.00155	0.00413	CbGeAlD
Vandetanib—EPHA5—brain—autistic disorder	0.00155	0.00413	CbGeAlD
Vandetanib—ABL2—cerebellum—autistic disorder	0.00155	0.00413	CbGeAlD
Vandetanib—FMO1—nervous system—autistic disorder	0.00155	0.00412	CbGeAlD
Vandetanib—LYN—brain—autistic disorder	0.00155	0.00411	CbGeAlD
Vandetanib—IRAK4—nervous system—autistic disorder	0.00152	0.00406	CbGeAlD
Vandetanib—BMPR1B—brain—autistic disorder	0.00152	0.00405	CbGeAlD
Vandetanib—MAP3K19—brain—autistic disorder	0.00152	0.00405	CbGeAlD
Vandetanib—ABL1—brainstem—autistic disorder	0.00152	0.00404	CbGeAlD
Vandetanib—EGFR—cerebellum—autistic disorder	0.00152	0.00403	CbGeAlD
Vandetanib—PDGFRB—telencephalon—autistic disorder	0.00151	0.00402	CbGeAlD
Vandetanib—YES1—digestive system—autistic disorder	0.00151	0.00401	CbGeAlD
Vandetanib—ERBB3—nervous system—autistic disorder	0.00149	0.00397	CbGeAlD
Vandetanib—STK10—digestive system—autistic disorder	0.00149	0.00397	CbGeAlD
Vandetanib—FMO1—central nervous system—autistic disorder	0.00149	0.00397	CbGeAlD
Vandetanib—MKNK1—head—autistic disorder	0.00148	0.00394	CbGeAlD
Vandetanib—ABL1—eye—autistic disorder	0.00148	0.00393	CbGeAlD
Vandetanib—RIPK2—cerebellum—autistic disorder	0.00147	0.00391	CbGeAlD
Vandetanib—IRAK4—central nervous system—autistic disorder	0.00147	0.0039	CbGeAlD
Vandetanib—VEGFA—cerebellum—autistic disorder	0.00146	0.0039	CbGeAlD
Vandetanib—FGR—head—autistic disorder	0.00146	0.00389	CbGeAlD
Vandetanib—RET—head—autistic disorder	0.00146	0.00389	CbGeAlD
Vandetanib—AXL—head—autistic disorder	0.00146	0.00387	CbGeAlD
Vandetanib—SRC—digestive system—autistic disorder	0.00145	0.00386	CbGeAlD
Vandetanib—ERBB3—central nervous system—autistic disorder	0.00144	0.00383	CbGeAlD
Vandetanib—IRAK4—cerebellum—autistic disorder	0.00143	0.00382	CbGeAlD
Vandetanib—FMO3—head—autistic disorder	0.00141	0.00376	CbGeAlD
Vandetanib—ERBB3—cerebellum—autistic disorder	0.00141	0.00374	CbGeAlD
Vandetanib—MKNK1—nervous system—autistic disorder	0.0014	0.00373	CbGeAlD
Vandetanib—FGR—nervous system—autistic disorder	0.00139	0.00369	CbGeAlD
Vandetanib—RET—nervous system—autistic disorder	0.00139	0.00369	CbGeAlD
Vandetanib—AXL—nervous system—autistic disorder	0.00138	0.00367	CbGeAlD
Vandetanib—FYN—head—autistic disorder	0.00136	0.00362	CbGeAlD
Vandetanib—MKNK1—central nervous system—autistic disorder	0.00135	0.00359	CbGeAlD
Vandetanib—ABL1—telencephalon—autistic disorder	0.00135	0.00359	CbGeAlD
Vandetanib—FMO3—nervous system—autistic disorder	0.00134	0.00356	CbGeAlD
Vandetanib—FGR—central nervous system—autistic disorder	0.00133	0.00355	CbGeAlD
Vandetanib—RET—central nervous system—autistic disorder	0.00133	0.00355	CbGeAlD
Vandetanib—KDR—digestive system—autistic disorder	0.00133	0.00355	CbGeAlD
Vandetanib—TEK—head—autistic disorder	0.00133	0.00354	CbGeAlD
Vandetanib—MAP4K5—head—autistic disorder	0.00133	0.00354	CbGeAlD
Vandetanib—AXL—central nervous system—autistic disorder	0.00133	0.00353	CbGeAlD
Vandetanib—MKNK1—cerebellum—autistic disorder	0.00132	0.00351	CbGeAlD
Vandetanib—RET—cerebellum—autistic disorder	0.0013	0.00347	CbGeAlD
Vandetanib—AXL—cerebellum—autistic disorder	0.0013	0.00346	CbGeAlD
Vandetanib—STK35—brain—autistic disorder	0.00129	0.00344	CbGeAlD
Vandetanib—FYN—nervous system—autistic disorder	0.00129	0.00344	CbGeAlD
Vandetanib—FMO3—central nervous system—autistic disorder	0.00129	0.00343	CbGeAlD
Vandetanib—EPHB6—head—autistic disorder	0.00127	0.00339	CbGeAlD
Vandetanib—MAP4K5—nervous system—autistic disorder	0.00126	0.00336	CbGeAlD
Vandetanib—TEK—nervous system—autistic disorder	0.00126	0.00336	CbGeAlD
Vandetanib—ABL2—brain—autistic disorder	0.00126	0.00335	CbGeAlD
Vandetanib—SLK—cerebellum—autistic disorder	0.00125	0.00333	CbGeAlD
Vandetanib—FYN—central nervous system—autistic disorder	0.00124	0.00331	CbGeAlD
Vandetanib—EGFR—brain—autistic disorder	0.00123	0.00327	CbGeAlD
Vandetanib—YES1—head—autistic disorder	0.00123	0.00327	CbGeAlD
Vandetanib—STK10—head—autistic disorder	0.00122	0.00324	CbGeAlD
Vandetanib—FYN—cerebellum—autistic disorder	0.00122	0.00323	CbGeAlD
Vandetanib—MAP4K5—central nervous system—autistic disorder	0.00122	0.00323	CbGeAlD
Vandetanib—TEK—central nervous system—autistic disorder	0.00122	0.00323	CbGeAlD
Vandetanib—EPHB6—nervous system—autistic disorder	0.00121	0.00321	CbGeAlD
Vandetanib—FLT4—brain—autistic disorder	0.0012	0.00319	CbGeAlD
Vandetanib—RIPK2—brain—autistic disorder	0.00119	0.00317	CbGeAlD
Vandetanib—VEGFA—brain—autistic disorder	0.00119	0.00317	CbGeAlD
Vandetanib—TEK—cerebellum—autistic disorder	0.00119	0.00316	CbGeAlD
Vandetanib—MAP4K5—cerebellum—autistic disorder	0.00119	0.00316	CbGeAlD
Vandetanib—FMO1—brain—autistic disorder	0.00118	0.00315	CbGeAlD
Vandetanib—SRC—head—autistic disorder	0.00118	0.00315	CbGeAlD
Vandetanib—YES1—nervous system—autistic disorder	0.00117	0.0031	CbGeAlD
Vandetanib—IRAK4—brain—autistic disorder	0.00117	0.0031	CbGeAlD
Vandetanib—EPHB6—central nervous system—autistic disorder	0.00116	0.00309	CbGeAlD
Vandetanib—STK10—nervous system—autistic disorder	0.00116	0.00307	CbGeAlD
Vandetanib—PDGFRB—digestive system—autistic disorder	0.00115	0.00307	CbGeAlD
Vandetanib—ERBB3—brain—autistic disorder	0.00114	0.00304	CbGeAlD
Vandetanib—EPHB6—cerebellum—autistic disorder	0.00114	0.00302	CbGeAlD
Vandetanib—YES1—central nervous system—autistic disorder	0.00112	0.00299	CbGeAlD
Vandetanib—SRC—nervous system—autistic disorder	0.00112	0.00298	CbGeAlD
Vandetanib—STK10—central nervous system—autistic disorder	0.00111	0.00296	CbGeAlD
Vandetanib—YES1—cerebellum—autistic disorder	0.0011	0.00292	CbGeAlD
Vandetanib—MAP2K5—head—autistic disorder	0.00109	0.00289	CbGeAlD
Vandetanib—KDR—head—autistic disorder	0.00109	0.00289	CbGeAlD
Vandetanib—STK10—cerebellum—autistic disorder	0.00109	0.00289	CbGeAlD
Vandetanib—SRC—central nervous system—autistic disorder	0.00108	0.00287	CbGeAlD
Vandetanib—MKNK1—brain—autistic disorder	0.00107	0.00285	CbGeAlD
Vandetanib—RET—brain—autistic disorder	0.00106	0.00282	CbGeAlD
Vandetanib—FGR—brain—autistic disorder	0.00106	0.00282	CbGeAlD
Vandetanib—SRC—cerebellum—autistic disorder	0.00106	0.00281	CbGeAlD
Vandetanib—AXL—brain—autistic disorder	0.00105	0.00281	CbGeAlD
Vandetanib—MAP2K5—nervous system—autistic disorder	0.00103	0.00274	CbGeAlD
Vandetanib—KDR—nervous system—autistic disorder	0.00103	0.00274	CbGeAlD
Vandetanib—ABL1—digestive system—autistic disorder	0.00103	0.00274	CbGeAlD
Vandetanib—ABCC1—telencephalon—autistic disorder	0.00103	0.00273	CbGeAlD
Vandetanib—FMO3—brain—autistic disorder	0.00102	0.00272	CbGeAlD
Vandetanib—SLK—brain—autistic disorder	0.00102	0.0027	CbGeAlD
Vandetanib—MAP2K5—central nervous system—autistic disorder	0.000993	0.00264	CbGeAlD
Vandetanib—KDR—central nervous system—autistic disorder	0.000993	0.00264	CbGeAlD
Vandetanib—FYN—brain—autistic disorder	0.000987	0.00263	CbGeAlD
Vandetanib—MAP2K5—cerebellum—autistic disorder	0.000971	0.00258	CbGeAlD
Vandetanib—KDR—cerebellum—autistic disorder	0.000971	0.00258	CbGeAlD
Vandetanib—MAP4K5—brain—autistic disorder	0.000965	0.00257	CbGeAlD
Vandetanib—TEK—brain—autistic disorder	0.000965	0.00257	CbGeAlD
Vandetanib—PDGFRB—head—autistic disorder	0.000942	0.00251	CbGeAlD
Vandetanib—EPHB6—brain—autistic disorder	0.000922	0.00245	CbGeAlD
Vandetanib—PDGFRB—nervous system—autistic disorder	0.000893	0.00238	CbGeAlD
Vandetanib—YES1—brain—autistic disorder	0.000891	0.00237	CbGeAlD
Vandetanib—STK10—brain—autistic disorder	0.000883	0.00235	CbGeAlD
Vandetanib—PDGFRB—central nervous system—autistic disorder	0.00086	0.00229	CbGeAlD
Vandetanib—SRC—brain—autistic disorder	0.000857	0.00228	CbGeAlD
Vandetanib—ABCG2—telencephalon—autistic disorder	0.00085	0.00226	CbGeAlD
Vandetanib—PDGFRB—cerebellum—autistic disorder	0.00084	0.00224	CbGeAlD
Vandetanib—ABL1—head—autistic disorder	0.000839	0.00223	CbGeAlD
Vandetanib—ORM1—nervous system—autistic disorder	0.000838	0.00223	CbGeAlD
Vandetanib—ORM1—central nervous system—autistic disorder	0.000806	0.00215	CbGeAlD
Vandetanib—ABL1—nervous system—autistic disorder	0.000796	0.00212	CbGeAlD
Vandetanib—MAP2K5—brain—autistic disorder	0.000789	0.0021	CbGeAlD
Vandetanib—KDR—brain—autistic disorder	0.000789	0.0021	CbGeAlD
Vandetanib—ABL1—central nervous system—autistic disorder	0.000766	0.00204	CbGeAlD
Vandetanib—ABL1—cerebellum—autistic disorder	0.000749	0.00199	CbGeAlD
Vandetanib—PDGFRB—brain—autistic disorder	0.000682	0.00182	CbGeAlD
Vandetanib—ABL1—brain—autistic disorder	0.000608	0.00162	CbGeAlD
Vandetanib—ABCC1—cerebellum—autistic disorder	0.00057	0.00152	CbGeAlD
Vandetanib—ALB—brain—autistic disorder	0.000561	0.00149	CbGeAlD
Vandetanib—ABCG2—cerebellum—autistic disorder	0.000472	0.00126	CbGeAlD
Vandetanib—ABCC1—brain—autistic disorder	0.000463	0.00123	CbGeAlD
Vandetanib—CYP3A4—digestive system—autistic disorder	0.000452	0.0012	CbGeAlD
Vandetanib—ABCG2—brain—autistic disorder	0.000384	0.00102	CbGeAlD
Vandetanib—CYP3A4—nervous system—autistic disorder	0.00035	0.00093	CbGeAlD
Vandetanib—CYP3A4—central nervous system—autistic disorder	0.000337	0.000895	CbGeAlD
Vandetanib—LCK—Hemostasis—HRAS—autistic disorder	7.77e-06	1.25e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—autistic disorder	7.75e-06	1.24e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AVP—autistic disorder	7.73e-06	1.24e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—MAPK1—autistic disorder	7.71e-06	1.24e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—APC—autistic disorder	7.71e-06	1.23e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IGF2—autistic disorder	7.7e-06	1.23e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PRKCB—autistic disorder	7.65e-06	1.23e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—POMC—autistic disorder	7.64e-06	1.22e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—EGF—autistic disorder	7.62e-06	1.22e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—PTEN—autistic disorder	7.62e-06	1.22e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PTEN—autistic disorder	7.61e-06	1.22e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PIK3CG—autistic disorder	7.6e-06	1.22e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APC—autistic disorder	7.6e-06	1.22e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HRAS—autistic disorder	7.59e-06	1.22e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PTEN—autistic disorder	7.58e-06	1.21e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—SERPINE1—autistic disorder	7.57e-06	1.21e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—autistic disorder	7.56e-06	1.21e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TCN2—autistic disorder	7.54e-06	1.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HTR2A—autistic disorder	7.54e-06	1.21e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—BCL2—autistic disorder	7.54e-06	1.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—autistic disorder	7.54e-06	1.21e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PTEN—autistic disorder	7.52e-06	1.21e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EGF—autistic disorder	7.51e-06	1.2e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—PTEN—autistic disorder	7.5e-06	1.2e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—autistic disorder	7.47e-06	1.2e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PIK3CG—autistic disorder	7.44e-06	1.19e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APC—autistic disorder	7.44e-06	1.19e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.43e-06	1.19e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EGF—autistic disorder	7.35e-06	1.18e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APC—autistic disorder	7.32e-06	1.17e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PIK3CG—autistic disorder	7.32e-06	1.17e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTGS2—autistic disorder	7.28e-06	1.17e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—autistic disorder	7.27e-06	1.16e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PLA2G4A—autistic disorder	7.27e-06	1.16e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—autistic disorder	7.27e-06	1.16e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HTR2A—autistic disorder	7.27e-06	1.16e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—HRAS—autistic disorder	7.26e-06	1.16e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EGF—autistic disorder	7.24e-06	1.16e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—POMC—autistic disorder	7.23e-06	1.16e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADA—autistic disorder	7.2e-06	1.15e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PTEN—autistic disorder	7.18e-06	1.15e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TSC2—autistic disorder	7.16e-06	1.15e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—POMC—autistic disorder	7.08e-06	1.13e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MEF2C—autistic disorder	7.07e-06	1.13e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PIK3CG—autistic disorder	7.06e-06	1.13e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—autistic disorder	7.02e-06	1.12e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—HRAS—autistic disorder	7.01e-06	1.12e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—HRAS—autistic disorder	7.01e-06	1.12e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LEP—autistic disorder	7.01e-06	1.12e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOE—autistic disorder	7.01e-06	1.12e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—HRAS—autistic disorder	7e-06	1.12e-05	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HRAS—autistic disorder	6.97e-06	1.12e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—POMC—autistic disorder	6.97e-06	1.12e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IGF1—autistic disorder	6.95e-06	1.11e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—autistic disorder	6.95e-06	1.11e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MAPK1—autistic disorder	6.94e-06	1.11e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—PTEN—autistic disorder	6.92e-06	1.11e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP19A1—autistic disorder	6.9e-06	1.11e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TSC2—autistic disorder	6.9e-06	1.11e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ITGB3—autistic disorder	6.89e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—autistic disorder	6.88e-06	1.1e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—HRAS—autistic disorder	6.88e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—autistic disorder	6.86e-06	1.1e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PTEN—autistic disorder	6.84e-06	1.1e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IGF1—autistic disorder	6.81e-06	1.09e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LEP—autistic disorder	6.75e-06	1.08e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOE—autistic disorder	6.75e-06	1.08e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—POMC—autistic disorder	6.72e-06	1.08e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HRAS—autistic disorder	6.72e-06	1.08e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—autistic disorder	6.71e-06	1.08e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—autistic disorder	6.71e-06	1.08e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IGF1—autistic disorder	6.7e-06	1.07e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—SERPINE1—autistic disorder	6.7e-06	1.07e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—autistic disorder	6.7e-06	1.07e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—BCL2—autistic disorder	6.67e-06	1.07e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—HRAS—autistic disorder	6.67e-06	1.07e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—autistic disorder	6.63e-06	1.06e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—autistic disorder	6.61e-06	1.06e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PRKCB—autistic disorder	6.61e-06	1.06e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—autistic disorder	6.61e-06	1.06e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SERPINE1—autistic disorder	6.6e-06	1.06e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PTEN—autistic disorder	6.6e-06	1.06e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—RORA—autistic disorder	6.56e-06	1.05e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.48e-06	1.04e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PTEN—autistic disorder	6.48e-06	1.04e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SERPINE1—autistic disorder	6.47e-06	1.04e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HTR2A—autistic disorder	6.43e-06	1.03e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—COMT—autistic disorder	6.42e-06	1.03e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GSTP1—autistic disorder	6.39e-06	1.02e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—autistic disorder	6.38e-06	1.02e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MAOA—autistic disorder	6.37e-06	1.02e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PRKCB—autistic disorder	6.37e-06	1.02e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SERPINE1—autistic disorder	6.37e-06	1.02e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTEN—autistic disorder	6.35e-06	1.02e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	6.35e-06	1.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PIK3CG—autistic disorder	6.33e-06	1.01e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APC—autistic disorder	6.33e-06	1.01e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—MAPK1—autistic disorder	6.32e-06	1.01e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—EGF—autistic disorder	6.25e-06	1e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—PTEN—autistic disorder	6.24e-06	1e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CAT—autistic disorder	6.21e-06	9.96e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—HRAS—autistic disorder	6.19e-06	9.92e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—MAPK1—autistic disorder	6.19e-06	9.92e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MAPK1—autistic disorder	6.18e-06	9.91e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—MAPK1—autistic disorder	6.16e-06	9.87e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MAOB—autistic disorder	6.15e-06	9.85e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MAPK1—autistic disorder	6.12e-06	9.8e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TSC2—autistic disorder	6.11e-06	9.79e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—MAPK1—autistic disorder	6.1e-06	9.77e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APC—autistic disorder	6.1e-06	9.77e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PIK3CG—autistic disorder	6.1e-06	9.77e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—autistic disorder	6.09e-06	9.76e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EGF—autistic disorder	6.03e-06	9.65e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—POMC—autistic disorder	6.02e-06	9.65e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTEN—autistic disorder	5.98e-06	9.58e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LEP—autistic disorder	5.98e-06	9.58e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOE—autistic disorder	5.98e-06	9.58e-06	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HRAS—autistic disorder	5.95e-06	9.53e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—autistic disorder	5.93e-06	9.5e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—autistic disorder	5.87e-06	9.41e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PLA2G4A—autistic disorder	5.87e-06	9.4e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GSTM1—autistic disorder	5.87e-06	9.4e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—autistic disorder	5.85e-06	9.37e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—MAPK1—autistic disorder	5.84e-06	9.36e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—POMC—autistic disorder	5.8e-06	9.3e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IGF1—autistic disorder	5.79e-06	9.28e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—MAPK1—autistic disorder	5.79e-06	9.27e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—MAPK1—autistic disorder	5.76e-06	9.24e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—PTEN—autistic disorder	5.76e-06	9.23e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TPH2—autistic disorder	5.72e-06	9.16e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PRKCB—autistic disorder	5.64e-06	9.03e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—MAPK1—autistic disorder	5.63e-06	9.02e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DPYD—autistic disorder	5.62e-06	9.01e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GPX1—autistic disorder	5.62e-06	9e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IGF1—autistic disorder	5.58e-06	8.94e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—HRAS—autistic disorder	5.57e-06	8.92e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MAPK1—autistic disorder	5.56e-06	8.91e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—PTEN—autistic disorder	5.53e-06	8.85e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SERPINE1—autistic disorder	5.5e-06	8.81e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APC—autistic disorder	5.4e-06	8.65e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PIK3CG—autistic disorder	5.4e-06	8.65e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MAPK1—autistic disorder	5.37e-06	8.6e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—autistic disorder	5.36e-06	8.59e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—autistic disorder	5.35e-06	8.56e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EGF—autistic disorder	5.33e-06	8.55e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—autistic disorder	5.33e-06	8.54e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTEN—autistic disorder	5.31e-06	8.51e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SERPINE1—autistic disorder	5.3e-06	8.49e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MAPK1—autistic disorder	5.27e-06	8.44e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—autistic disorder	5.23e-06	8.39e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CACNA1C—autistic disorder	5.23e-06	8.38e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MTHFR—autistic disorder	5.19e-06	8.31e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—MAPK1—autistic disorder	5.16e-06	8.27e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—autistic disorder	5.15e-06	8.26e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—autistic disorder	5.14e-06	8.23e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTEN—autistic disorder	5.1e-06	8.18e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	5.09e-06	8.16e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HRAS—autistic disorder	5.08e-06	8.14e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—MAPK1—autistic disorder	5.08e-06	8.13e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PTEN—autistic disorder	5.03e-06	8.06e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—HRAS—autistic disorder	4.97e-06	7.96e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—HRAS—autistic disorder	4.96e-06	7.95e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HRAS—autistic disorder	4.95e-06	7.93e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IGF1—autistic disorder	4.94e-06	7.92e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PTEN—autistic disorder	4.92e-06	7.89e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—HRAS—autistic disorder	4.91e-06	7.87e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—HRAS—autistic disorder	4.89e-06	7.84e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—autistic disorder	4.88e-06	7.81e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—MAPK1—autistic disorder	4.86e-06	7.79e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—autistic disorder	4.86e-06	7.79e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PTEN—autistic disorder	4.85e-06	7.77e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOE—autistic disorder	4.83e-06	7.74e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—autistic disorder	4.76e-06	7.62e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DHFR—autistic disorder	4.76e-06	7.62e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—autistic disorder	4.75e-06	7.61e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—autistic disorder	4.74e-06	7.59e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—autistic disorder	4.7e-06	7.53e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SERPINE1—autistic disorder	4.69e-06	7.52e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—HRAS—autistic disorder	4.69e-06	7.51e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—MAPK1—autistic disorder	4.69e-06	7.51e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—autistic disorder	4.68e-06	7.5e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTEN—autistic disorder	4.68e-06	7.49e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—HRAS—autistic disorder	4.64e-06	7.44e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—HRAS—autistic disorder	4.63e-06	7.41e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—HRAS—autistic disorder	4.52e-06	7.24e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—MAPK1—autistic disorder	4.49e-06	7.2e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—autistic disorder	4.49e-06	7.19e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—HRAS—autistic disorder	4.46e-06	7.15e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—autistic disorder	4.45e-06	7.13e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—autistic disorder	4.43e-06	7.1e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PIK3CG—autistic disorder	4.36e-06	6.98e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—autistic disorder	4.32e-06	6.93e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—HRAS—autistic disorder	4.31e-06	6.91e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—autistic disorder	4.29e-06	6.87e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—autistic disorder	4.27e-06	6.84e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HRAS—autistic disorder	4.23e-06	6.77e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PTEN—autistic disorder	4.19e-06	6.71e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—MAPK1—autistic disorder	4.15e-06	6.65e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—autistic disorder	4.15e-06	6.65e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—HRAS—autistic disorder	4.14e-06	6.64e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—autistic disorder	4.13e-06	6.61e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MAPK1—autistic disorder	4.09e-06	6.55e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—HRAS—autistic disorder	4.07e-06	6.53e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—autistic disorder	4.05e-06	6.48e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PTEN—autistic disorder	4.04e-06	6.47e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MAPK1—autistic disorder	4e-06	6.41e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—autistic disorder	3.96e-06	6.35e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MAPK1—autistic disorder	3.94e-06	6.31e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—HRAS—autistic disorder	3.9e-06	6.25e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—autistic disorder	3.9e-06	6.25e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—autistic disorder	3.8e-06	6.08e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—HRAS—autistic disorder	3.76e-06	6.03e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—autistic disorder	3.74e-06	5.99e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.73e-06	5.97e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—HRAS—autistic disorder	3.61e-06	5.78e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—autistic disorder	3.6e-06	5.77e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTEN—autistic disorder	3.57e-06	5.73e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—COMT—autistic disorder	3.46e-06	5.55e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—autistic disorder	3.45e-06	5.53e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTP1—autistic disorder	3.45e-06	5.52e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MAOA—autistic disorder	3.44e-06	5.51e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MAPK1—autistic disorder	3.4e-06	5.46e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CAT—autistic disorder	3.35e-06	5.38e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—HRAS—autistic disorder	3.33e-06	5.34e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—autistic disorder	3.31e-06	5.3e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—HRAS—autistic disorder	3.28e-06	5.26e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MAPK1—autistic disorder	3.28e-06	5.26e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—HRAS—autistic disorder	3.21e-06	5.15e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—autistic disorder	3.19e-06	5.11e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.17e-06	5.08e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTM1—autistic disorder	3.17e-06	5.08e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—HRAS—autistic disorder	3.16e-06	5.07e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—autistic disorder	3.14e-06	5.03e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—autistic disorder	3.08e-06	4.93e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GPX1—autistic disorder	3.03e-06	4.86e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—autistic disorder	3.03e-06	4.85e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MAPK1—autistic disorder	2.9e-06	4.65e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTEN—autistic disorder	2.89e-06	4.62e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MTHFR—autistic disorder	2.8e-06	4.49e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—HRAS—autistic disorder	2.73e-06	4.38e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—HRAS—autistic disorder	2.63e-06	4.22e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—autistic disorder	2.62e-06	4.19e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOE—autistic disorder	2.61e-06	4.18e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—autistic disorder	2.52e-06	4.04e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.35e-06	3.77e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—HRAS—autistic disorder	2.33e-06	3.74e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—autistic disorder	2.24e-06	3.59e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—autistic disorder	2.23e-06	3.58e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—autistic disorder	1.79e-06	2.86e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTEN—autistic disorder	1.56e-06	2.5e-06	CbGpPWpGaD
